About Oto
Oto is a company based in London (United Kingdom) founded in 2020 by Edmund Farrar. It operates as a HealthTech and Subscription Services. Oto has raised $4.11 million across 2 funding rounds from investors including Bethnal Green Ventures, Calm/Storm and Octopus Ventures. The company has 10 employees as of December 31, 2023. Oto offers products and services including Oto Tinnitus Program. Oto operates in a competitive market with competitors including Appyhapps, Quadio, Tonal Tinnitus Therapy, AudioCardio and Kalmeda, among others.
- Headquarter London, United Kingdom
- Employees 10 as on 31 Dec, 2023
- Founders Edmund Farrar
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Oto Health Ltd
- Date of Incorporation 27 Sep, 2019
- Jurisdiction LONDON, ENGLAND
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$4.11 M (USD)
in 2 rounds
-
Latest Funding Round
$3.41 M (USD), Seed
Jul 13, 2022
-
Investors
Bethnal Green Ventures
& 11 more
-
Employee Count
10
as on Dec 31, 2023
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Oto
Oto offers a comprehensive portfolio of products and services, including Oto Tinnitus Program.
A guided program to manage tinnitus through audio sessions.
Funding Insights of Oto
Oto has successfully raised a total of $4.11M across 2 strategic funding rounds. The most recent funding activity was a Seed round of $3.41 million completed in July 2022. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Oto
Oto has secured backing from 12 investors, including venture fund, institutional, and angel investors. Prominent investors backing the company include Bethnal Green Ventures, Calm/Storm and Octopus Ventures.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Venture capital investment and support for founders in technology and health sectors.
|
Locked | Locked | Locked | |
|
Early-stage startups are accelerated via funding and educational programs.
|
Locked | Locked | Locked | |
|
Early-stage venture capital investments are focused on startups.
|
Locked | Locked | Locked |
Investor details for Oto
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Oto
Investment portfolio details for Oto
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Oto
Detailed financials for Oto
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Oto Comparisons
Peer comparison for Oto
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Oto
Oto operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Appyhapps, Quadio, Tonal Tinnitus Therapy, AudioCardio and Kalmeda, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Develops Android and iOS apps for health data syncing and tinnitus therapy services.
|
|
| Locked | Locked | Locked |
Hearing management solutions are delivered via aids and tele-audiology services.
|
|
| Locked | Locked | Locked |
Provides app-based sound therapy to identify and manage tinnitus frequencies effectively.
|
|
| Locked | Locked | Locked |
AudioCardio provides AI diagnostics and therapies for hearing health via mobile app.
|
|
| Locked | Locked | Locked |
App for tinnitus management
|
Detailed competitors of Oto
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Oto
Complete news archive for Oto
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Oto
Oto was founded in 2020 and raised its 1st funding round 2 years after it was founded.
Oto is headquartered in London, United Kingdom. It is registered at London, England, United Kingdom.
Edmund Farrar is the current CEO of Oto. They have also founded this company.
Oto is a funded company, having raised a total of $4.11M across 2 funding rounds to date.
As of Dec 31, 2023, the latest employee count at Oto is 10.
A digital health solution is provided by Oto to help individuals manage tinnitus through a clinically-proven program. Daily audio sessions and cognitive behavioral therapy techniques are utilized to retrain the brains response to tinnitus. The service is delivered at home, requiring only ten minutes a day. Collaboration with top tinnitus specialists and researchers ensures credibility. The program is supported by clinical trials conducted with prestigious institutions like the University of Cambridge. Services are accessible globally through a network of over 300 clinicians and telehealth providers in the US.
Oto offers Oto Tinnitus Program.
Oto has 12 investors. Key investors include Bethnal Green Ventures, Calm/Storm, Octopus Ventures, Y Combinator, and Goodwater Capital.